Literature DB >> 7737036

Pharmacokinetics in the elderly.

M Mayersohn1.   

Abstract

Animals undergo substantial changes in many physiologic and biochemical functions as a natural consequence of aging. In the absence of disease or other pathologic conditions, these changes occur in a gradual manner with time (generally expressed as a fractional or percentage change in that function per year or decade). Furthermore, for any given function and at any given chronologic age, there is large variation in that function among individuals. Given the increase in life expectancy, the substantial increase in the number of elderly (and aged elderly) in the population, and the escalating costs of health care, there is great interest in learning more about the risks associated with aging as a result of toxic exposure. Are the elderly at greater risk than younger adults to the toxic effects of drugs and environmental exposure? Is the elderly population an inherently more sensitive one?

Entities:  

Mesh:

Year:  1994        PMID: 7737036      PMCID: PMC1566768          DOI: 10.1289/ehp.94102s11119

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  29 in total

1.  Splanchnic blood flow in man by the bromsulfalein method: the relation of peripheral plasma bromsulfalein level to the calculated flow.

Authors:  S SHERLOCK; A G BEARN; B H BILLING; J C S PATERSON
Journal:  J Lab Clin Med       Date:  1950-06

2.  Senescence and the renal vasculature in normal man.

Authors:  N K Hollenberg; D F Adams; H S Solomon; A Rashid; H L Abrams; J P Merrill
Journal:  Circ Res       Date:  1974-03       Impact factor: 17.367

3.  Metabolism and absorption of L-3,4 dihydroxyphenylalanine in patients with Parkinson's disease.

Authors:  J R Bianchine; L R Calimlim; J P Morgan; C A Dujuvne; L Lasagna
Journal:  Ann N Y Acad Sci       Date:  1971-07-06       Impact factor: 5.691

4.  Age changes in small-intestinal mucosa.

Authors:  P M Warren; M A Pepperman; R D Montgomery
Journal:  Lancet       Date:  1978-10-14       Impact factor: 79.321

5.  Reduced serum albumin concentration in the elderly: a report from the Boston Collaborative Drug Surveillance Program.

Authors:  D J Greenblatt
Journal:  J Am Geriatr Soc       Date:  1979-01       Impact factor: 5.562

6.  Ascorbic acid absorption in man: influence of divided dose and food.

Authors:  S Yung; M Mayersohn; J B Robinson
Journal:  Life Sci       Date:  1981-06-01       Impact factor: 5.037

7.  Factors affecting the absorption of riboflavin in man.

Authors:  G Levy; W J Jusko
Journal:  J Pharm Sci       Date:  1966-03       Impact factor: 3.534

8.  Antipyrine disposition and liver size in the elderly.

Authors:  C G Swift; M Homeida; M Halliwell; C J Roberts
Journal:  Eur J Clin Pharmacol       Date:  1978-11-16       Impact factor: 2.953

9.  The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man.

Authors:  C J Roberts; L Jackson; M Halliwell; R A Branch
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

10.  Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination.

Authors:  A J Wood; R E Vestal; G R Wilkinson; R A Branch; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1979-07       Impact factor: 6.875

View more
  7 in total

Review 1.  Adverse drug reactions in older people: detection and prevention.

Authors:  Mirko Petrovic; Tischa van der Cammen; Graziano Onder
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

Review 2.  Optimal treatment of heart failure in the elderly.

Authors:  R Doughty; V Andersen; N Sharpe
Journal:  Drugs Aging       Date:  1997-06       Impact factor: 3.923

Review 3.  Principles of drug administration in renal insufficiency.

Authors:  Y W Lam; S Banerji; C Hatfield; R L Talbert
Journal:  Clin Pharmacokinet       Date:  1997-01       Impact factor: 6.447

4.  Total and methyl mercury in whole blood measured for the first time in the U.S. population: NHANES 2011-2012.

Authors:  Mary E Mortensen; Samuel P Caudill; Kathleen L Caldwell; Cynthia D Ward; Robert L Jones
Journal:  Environ Res       Date:  2014-08-29       Impact factor: 6.498

5.  Lack of age and gender effects on single-dose pharmacokinetics of tomopenem (RO4908463/CS-023), a novel carbapenem.

Authors:  Navita L Mallalieu; Siân Lennon; Thorold Guy; Mei Liu; Eric Luedin; Brian E Davies
Journal:  Br J Clin Pharmacol       Date:  2009-04       Impact factor: 4.335

6.  Aging and the environment: a research framework.

Authors:  Andrew M Geller; Harold Zenick
Journal:  Environ Health Perspect       Date:  2005-09       Impact factor: 9.031

Review 7.  Diabetic Retinopathy in the Aging Population: A Perspective of Pathogenesis and Treatment.

Authors:  Sameer P Leley; Thomas A Ciulla; Ashay D Bhatwadekar
Journal:  Clin Interv Aging       Date:  2021-07-15       Impact factor: 4.458

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.